Rapid Micro Biosystems Inc.
RPID | NASDAQ
$1.17
+$0.04 (+3.54%)
Sep 22, 2026, 11:56 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 33.59M | 28.05M | 22.52M | 17.13M | 23.23M | 16.08M |
Cost of Revenue | 25.98M | 28.16M | 28M | 25.67M | 30.97M | 24.15M |
Gross Profit | 7.61M | -109K | -5.49M | -8.54M | -7.74M | -8.07M |
Operating Income | -47.39M | -49.92M | -56.56M | -63.22M | -47.23M | -30.54M |
Interest Income | 1.51M | 3.16M | 4.21M | 1.78M | n/a | n/a |
Pretax Income | -47.08M | -46.87M | -52.44M | -61.38M | -73.43M | -36.94M |
Net Income | -47.12M | -46.89M | -52.47M | -60.81M | -73.52M | -37.08M |
Selling & General & Admin | 34.84M | 35.21M | 38.26M | 41.81M | 29.71M | 15.94M |
Research & Development | 13.6M | 14.6M | 12.82M | 12.87M | 9.78M | 6.53M |
Other Expenses | 6.56M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 55M | 49.81M | 51.08M | 54.68M | 39.49M | 22.47M |
Interest Expense | 1.09M | n/a | n/a | n/a | 2.65M | 3.45M |
Selling & Marketing Expenses | 12.08M | 13.27M | 13.32M | 14.99M | 11.82M | 5.96M |
Cost & Expenses | 80.98M | 77.97M | 79.08M | 80.35M | 70.46M | 46.62M |
Income Tax Expense | 40K | 22K | 31K | -576K | 91K | 134K |
Shares Outstanding (Basic) | 44.68M | 43.58M | 43.02M | 42.45M | 41.47M | 38.67M |
Shares Outstanding (Diluted) | 44.68M | 43.58M | 43.02M | 42.45M | 41.47M | 38.67M |
EPS (Basic) | -1.05 | -1.08 | -1.22 | -1.43 | -1.88 | -1.17 |
EPS (Diluted) | -1.05 | -1.08 | -1.22 | -1.43 | -1.88 | -1.17 |
EBITDA | -42.74M | -43.51M | -49.33M | -58.55M | -69.25M | -32M |
EBIT | -45.99M | -46.87M | -52.44M | -61.38M | -70.78M | -33.5M |
Depreciation & Amortization | 3.25M | 3.36M | 3.11M | 2.84M | 1.53M | 1.5M |
Add to Watchlist
Select watchlists to add or remove RPID